Anal fissures associated with targeted therapies in ovarian cancer.
Although ovarian cancer remains a leading cause of gynecologic cancer death, targeted therapies are improving patient outcomes. Anal fissures are a side effect of targeted therapies that can disrupt or stop treatment regimens. Diagnosis and management of anal fissures by advanced practice nurses are crucial for maintaining the quality of life of patients with ovarian cancer.
Squires
Jennifer
J
Medical Oncology Branch of the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. squiresj@mail.nih.gov
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001004:Anus Diseases / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents